NSC |
Compound |
Enrichment |
Correlation |
NSC 746035 |
2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone |
0.045446901295916 |
0.14270362 |
NSC 749117 |
3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline |
0.045446901295916 |
0.40537449 |
NSC 750335 |
(E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one |
0.045446901295916 |
0.029976594 |
NSC 753218 |
3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline |
0.045446901295916 |
0.20309026 |
NSC 88903 |
Null |
0.045446901295916 |
0.30941962 |
NSC 92915 |
ANTINEOPLASTIC-92915 |
0.045446901295916 |
0.12803846 |
NSC 9598 |
3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride |
0.045446901295916 |
0.42393311 |
NSC 116693 |
Null |
0.0454469012959173 |
0.1475049 |
NSC 131258 |
Null |
0.0454469012959173 |
0.31279474 |
NSC 154829 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride |
0.0454469012959173 |
0.4028014 |